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Abstract. 
 
The perinucleolar compartment (PNC) is a 
unique nuclear structure preferentially localized at the 
periphery of the nucleolus. Several small RNAs tran-
scribed by RNA polymerase III (e.g., the Y RNAs, 
MRP RNA, and RNase P H1 RNA) and the polypyrim-
idine tract binding protein (PTB; hnRNP I) have thus 
far been identified in the PNC (Ghetti, A., S. Pinol-
Roma, W.M. Michael, C. Morandi, and G. Dreyfuss. 
 
1992. 
 
Nucleic Acids Res.
 
 20:3671–3678; Matera, A.G., 
M.R. Frey, K. Margelot, and S.L. Wolin. 1995. 
 
J. Cell 
Biol.
 
 129:1181–1193; Lee, B., A.G. Matera, D.C. Ward, 
and J. Craft. 1996. 
 
Proc. Natl. Acad. Sci. USA.
 
 93:
11471–11476). In this report, we have further character-
ized this structure in both fixed and living cells. Detec-
tion of the PNC in a large number of human cancer and 
normal cells showed that PNCs are much more preva-
lent in cancer cells. Analysis through the cell cycle us-
ing immunolabeling with a monoclonal antibody, SH54, 
specifically recognizing PTB, demonstrated that the 
PNC dissociates at the beginning of mitosis and reforms 
at late telophase in the daughter nuclei. To visualize the 
PNC in living cells, a fusion protein between PTB and 
green fluorescent protein (GFP) was generated. Time 
lapse studies revealed that the size and shape of the 
PNC is dynamic over time. In addition, electron micro-
scopic examination in optimally fixed cells revealed 
that the PNC is composed of multiple strands, each 
 
measuring 
 
z
 
80–180 nm diam. Some of the strands are 
in direct contact with the surface of the nucleolus. Fur-
thermore, analysis of the sequence requirement for tar-
geting PTB to the PNC using a series of deletion mu-
tants of the GFP–PTB fusion protein showed that at 
 
least three RRMs at either the COOH or NH
 
2
 
 terminus 
are required for the fusion protein to be targeted to the 
PNC. This finding suggests that RNA binding may be 
necessary for PTB to be localized in the PNC.
M
 
any
 
 nuclear functions including DNA replica-
tion, RNA transcription, processing, and trans-
port have been extensively investigated at the
biochemical and molecular levels. However, much less is
understood regarding the spatial organization of these
events within the three-dimensional context of the mam-
malian cell nucleus. Light and electron microscopic exami-
nation of cell nuclei has revealed many readily identifiable
nuclear structures including the nucleolus, electron dense
heterochromatin, and a variety of granular and fibrillar
structures including interchromatin granules, perichroma-
tin granules, and perichromatin fibrils (for review see
Spector, 1993). The use of increasingly sophisticated mo-
lecular techniques and the availability of a large number of
antibodies and also nucleic acid probes has advanced our
understanding of the temporal and spatial organization of
nuclear functions, as well as revealed the complex nature
of the mammalian cell nucleus.
In addition to the ubiquitous features of the nucleus, nu-
 
clear bodies have been described in specific cell types or
cells at different physiological states (Bouteille et al., 1967).
One of the more extensively studied examples is the coiled
body. Coiled bodies were first described by Ramon and
Cajal (1903) as nucleolar accessory bodies. These gener-
ally round structures, 0.5–1.0 
 
m
 
m diam, consist of coiled
fibrillar strands (Monneron and Bernhard, 1969). In addi-
tion to small nuclear RNPs, several nucleolar components
and a coiled body–specific protein, coilin, have been found
in these structures (for reviews see Brasch and Ochs, 1992;
Lamond and Carmo-Fonseca, 1993; Gall et al., 1995).
However, [
 
3
 
H]uridine incorporation studies showed little
to no labeling of these bodies after a short pulse (Moreno
Diaz de la Espina et al., 1980), suggesting that coiled bod-
ies are unlikely to be the sites of active RNA synthesis. In
addition, the absence of essential pre-mRNA splicing fac-
tors such as SC35 and SF2/ASF (Raska et al., 1991; Huang
and Spector, 1992; Lamond and Carmo-Fonseca, 1993;
Krainer, A., and D. Spector, unpublished observations) in
these structures suggests that they are probably not the
sites of active splicing. The number of coiled bodies per
nucleus and the percentage of cells that contain coiled
bodies increase dramatically in immortalized cells or can-
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cer cells as compared to primary cells (Spector et al., 1992).
In addition, coiled bodies have been found to be within the
nucleoli in some cell lines derived from breast cancer
tissues (Ochs et al., 1994). However, the function of the
coiled body remains elusive. More recently, a novel nuclear
structure, gems, was identified in close proximity to coiled
bodies (Liu and Dreyfuss, 1996). Gems are similar to
coiled bodies in number and size, response to metabolic
conditions, and their dynamics through the cell cycle. How-
ever, gems and coiled bodies contain different macromo-
lecular components. Survival of motor neuron protein,
involved in the genetic disease spinal muscular atrophy,
is localized in gems. Components that are localized in
coiled bodies such as snRNPs, coilin, and fibrillarin are not
present in gems (Liu and Dreyfuss, 1996). The function of
gems is currently unknown.
Another intensively studied nuclear body is the promye-
locyte (PML)
 
1
 
 oncogenic domain (POD), also named PML
or ND10, which consists of a dense fibrillar ring flanking a
central core (Ascoli and Maul, 1991; Dyck et al., 1994; Ko-
ken et al., 1994, 1995; Weis et al., 1994; Terris et al., 1995).
The POD was defined by immunolabeling with an anti-
body specifically recognizing the PML protein in hemato-
poietic cells. Several other autoimmune antibodies also re-
act with components in the POD (Ascoli and Maul, 1991).
The POD becomes fragmented into a large number of mi-
croparticulates in acute promyelocytic leukemia (Dyck et
al., 1994; Koken et al., 1994; Weis et al., 1994). The break
up of the POD into microparticulates is related to the for-
mation of the PML–retinoic acid receptor 
 
a
 
 fusion protein
resulting from a t(15;17) translocation (Dyck et al., 1994;
Koken et al., 1994; Weis et al., 1994). When these cells are
treated with retinoic acid, the fragmented PML particu-
lates fuse and reassemble into PODs along with the initia-
tion of cellular differentiation and the loss of the PML–ret-
inoic acid receptor 
 
a
 
 fusion protein. This observation
provided evidence that alterations of nuclear structure
may play a role in this form of carcinogenesis (Dyck et al.,
1994; Koken et al., 1994; Weis et al., 1994). In addition to
being present in hematopoietic cells, the POD has recently
been detected in a variety of tissues including hepatocytes,
endothelium, epithelium, and connective stroma (Koken
et al., 1995; Terris et al., 1995). The expression of PML and
its immunolabeling pattern, in some of the samples exam-
ined, appeared to change depending upon the proliferat-
ing or cancer state. However, the function of the POD is
presently unknown.
More recently, a unique structure localized at the pe-
riphery of the nucleolus, the perinucleolar compartment
(PNC), was identified (Ghetti et al., 1992; Matera et al.,
1995). The PNC has been shown to contain several small
RNAs transcribed by RNA polymerase III, including
RNase P, MRP RNAs, and multiple Y RNAs (Matera et
al., 1995; Lee et al., 1996), as well as the polypyrimidine
tract binding protein (PTB; Ghetti et al., 1992; Matera et
al., 1995). However, the structural and functional charac-
teristics of the PNC have not yet been extensively studied.
 
In this paper, we examined the PNC in human cancer and
normal cell lines. We also characterized the PNC in fixed
cells using light and electron microscopy and in living cells
through time lapse observations. In addition, we analyzed
the sequence requirements to target a green fluorescent
protein (GFP)–PTB fusion protein to the PNC.
 
Materials and Methods
 
Cell Culture
 
Several human cell lines were grown to subconfluence on 22 
 
3
 
 22 mm
glass coverslips in 35-mm Petri dishes in the appropriate culture medium.
HeLa (epithelial carcinoma, cervix), T84 (colon carcinoma), SW620 (co-
lon adenocarcinoma), WI-38 VA13 (WI-38 cells transformed with SV40
T), Wacar (normal skin fibroblasts), Homa (normal skin fibroblasts), and
MRC5 (normal lung fibroblasts) were grown in DME supplemented with
10% fetal bovine serum (GIBCO BRL, Gaithersburg, MD). The breast
cancer cell lines including MDA-MB-468 (adenocarcinoma) and Hs 578T
(ductal carcinoma) cells were grown in DME supplemented with 15%
FBS. Normal human mammary epithelium (NHME) cells were grown in
mammary epithelium basal medium (MEBM) supplemented with 5 mg/li-
ter transferrin, 1 mg/liter hydrocortisone, 5 
 
m
 
M isoproterenol, 10 mg/liter
insulin, 5 
 
m
 
g/liter epithelium growth factor (EGF), and 0.2% bovine pitu-
itary extract. MG63 (osteosarcoma), Detroit 551 (normal skin fibroblasts),
and WI-38 (normal lung fibroblasts) cells were grown in minimal essential
medium (MEM) supplemented with 10% FBS. Cells were maintained at
37
 
8
 
C with 10% CO
 
2
 
.
 
Construction of GFP Fusion Proteins
 
Human PTB cDNA (Gil et al., 1991) was amplified by PCR using Vent
DNA polymerase (New England Biolabs Inc., Beverly, MA). The ampli-
fied fragment was inserted in frame into a GFP expression construct,
pEGFP-C1 (Clontech Laboratories, Inc., Palo Alto, CA), at the HindIII
and BamH1 sites. The fusion protein contained GFP at the NH
 
2
 
 terminus
of PTB. Subsequently, deletion fragments of PTB were generated by PCR
using specific primers and were inserted into pEGFP-C1, which gave rise
to a series of mutant fusion proteins.
 
Transfection
 
Expression constructs were transiently transfected into HeLa cells by
electroporation (Sambrook et al., 1989). Briefly, subconfluent cells in a
100-mm culture dish were collected by trypsinization and mixed with 20 
 
m
 
g
of DNA including 7 
 
m
 
g target DNA and 13 
 
m
 
g sheared salmon sperm
DNA. A 280 
 
m
 
l mixture of cells in DME with 10% FCS and DNA was
electroporated in a BioRad (Richmond, CA) electroporator at 270 V and
960 
 
m
 
Faraday. Cells were subsequently seeded onto glass coverslips in 35-
mm petri dishes and were grown for either 7 or 24 h.
 
Immunolabeling
 
SH54 monoclonal antibody was raised against HeLa nuclear extracts. The
antibody was selected by its specific labeling of the PNC in the nucleus.
SH54 recognizes a 57-kD protein on a Western blot (see Fig. 4 
 
A
 
) and was
confirmed to bind PTB specifically.
Subconfluent cells grown on the glass coverslips were fixed in freshly
made 2% formaldehyde in PBS for 15 min, and cells were washed 3 
 
3
 
 10
min each in PBS and incubated with anti-PTB primary antibody SH54 at a
dilution of 1:300, anti-Sm antibody (Lerner and Steitz, 1979) at 1:1,000,
anti-SC35 (Fu and Maniatis, 1990) at 1:1,000, or anti-fibrillarin (Sigma
Chemical Co., St. Louis, MO) at 1:5 for 1 h at room temperature. Cells
were rinsed in PBS and then incubated with Texas red–conjugated goat
anti–human or FITC-conjugated goat anti–mouse antibody at a dilution of
1:40 for 1 h at room temperature followed by three washes in PBS. The
coverslips were mounted onto glass slides with mounting medium contain-
ing 90% glycerol in PBS with 1 mg/ml paraphenylenediamine as an anti-
fade agent. The mounting medium was adjusted to pH 8.0 with 0.2 M bi-
carbonate buffer. Cells were examined with a microscope (FXA; Nikon
Inc., Melville, NY) equipped with epifluorescence and differential inter-
ference contrast optics. Images were captured by a SenSys cooled CCD
camera (Photometrics, Tucson, AZ) using Oncor Image software.
 
1. 
 
Abbreviations used in this paper
 
: GFP, green fluorescent protein; PML,
promyelocyte; PNC, perinucleolar complex; POD, PML oncogenic do-
main; PTB, polypyrimidine tract binding protein; RRM, RNA recognition
motif.
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Photooxidation
 
Immunoelectron microscopic localization was performed according to the
preembedding photooxidation procedure (Deerinck et al., 1994). After in-
cubation of the primary antibody (as described in the immunolabeling
procedure), cells were washed twice for 2 min in 0.1 M PBS and incubated
in 0.1 M PBS with 1% normal goat serum (NGS), 1% cold water fish gela-
tin, and 1% BSA (fraction V) for 20 min to block nonspecific staining.
Cells were then incubated with goat anti–mouse eosin-5-isothiocyanate
(conjugated as previously described, Deerinck et al., 1994) diluted in 0.1 M
PBS with 1% BSA and 1% NGS for 1 h. Unbound conjugate was re-
moved by washing six times for 5 min in 0.1 M PBS with 1% BSA and 1%
NGS followed by two times in 5 min washes with 0.1 M sodium cacody-
late, pH 7.4. All washes and incubations were at 4
 
8
 
C.
Cells were examined using a 35-mm microscope (Axiovert; Zeiss Inc.)
equipped with an MRC-1024 laser scanning confocal system (BioRad) us-
ing the 488 nm excitation line from an argon/krypton laser. During imag-
ing the cells were kept at 10
 
8
 
C using a cold stage and were in 0.1 M sodium
cacodylate that had been deoxygenated by bubbling with argon to retard
photobleaching.
Once an area had been selected using a 40
 
3
 
 1.3 NA objective (Pla-
napo; Zeiss Inc.), a cold oxygenated solution of 1 mg/ml diaminobenzidine
tetrahydrochloride (DAB; Sigma Chemical Co.) in 0.1 M sodium cacody-
late, pH 7.2, was added to the cells. Photooxidation of the DAB by eosin
was accomplished by illuminating the region of interest with 515 nm light
from 100 W mercury lamp. The progress of the reaction was monitored by
transmitted light, and illumination was halted when a brownish reaction
product became visible (10–20 min). Both experimental and control prep-
arations were reacted under identical conditions.
After photooxidation, the cells were rinsed five times for 2 min in 0.1 M
sodium cacodylate and then postfixed in 1% osmium tetroxide for 1 h.
Cells were then rinsed in double distilled water, dehydrated in an ethanol
series, and infiltrated with Durcupan ACM resin (Electron Microscopy
Sciences, Ft. Washington, PA). After polymerization of the resin for 24 h
at 60
 
8
 
C, the bottom glass coverslip was removed from the dish, and the re-
gion of interest was cut out and mounted for ultramicrotomy with an ultra-
microtome (Ultracut E; Leica Inc., Deerfield, IL) using a diamond knife
(Diatome U.S., Ft. Washington, PA). Electron micrographs were re-
corded from sections 80 nm in thickness at 60–80 kV with a transmission
electron microscope (100CX; Jeol Ltd., Tokyo, Japan) and sections 1 
 
m
 
m
thick at 300 kV with an intermediate voltage transmission electron micro-
scope (4000EX; Jeol Ltd.). Stereo-pair images were recorded by tilting the
specimen stage to 
 
6 
 
8
 
8
 
. Sections of photooxidized cells were not post-
stained.
 
Structural Characterization by Correlative
Electron Microscopy
 
To examine the structure of the PNC in optimally fixed cells at high reso-
lution, transiently expressed GFP–PTB was used as a marker to indicate
the localization of the PNC. The corresponding nuclear region identified
by fluorescence of the GFP–PTB fusion protein was examined by electron
microscopy. Specifically, transfected cells were seeded on gridded cover-
slips. 12 h after transfection, cells were fixed in 4% paraformaldehyde
with 0.05% glutaraldehyde in PBS, and cells that showed the PNC were
quickly examined and photographed using an epifluorescence microscope
(FXA; Nikon Inc.) equipped with a SenSys cooled CCD camera (Photomet-
rics Inc., Tucson, AZ) using Oncor Image software. Subsequently, cells
were fixed in 2% glutaraldehyde for 20 min and washed in PBS containing
0.3 M glycine and 0.1 M cacodylate buffer. Cells were then postfixed in
1% osmium tetroxide for 1 h and dehydrated by incubation in a series of
ascending concentrations of ethanol and embedded in epon/araldite at
60
 
8
 
C for 48 h. 80-nm sections were poststained with uranyl acetate/lead ci-
trate and examined at 75 kV with a transmission electron microscope
(H-7000; Hitachi Scientific Instrs., Mountain View, CA). The same cell
photographed at the fluorescence microscopic level was located, and the
nuclear region that corresponded to the PNC was identified and photo-
graphed.
 
Observation of the PNC in Living Cells
 
Living cell studies were performed using an FCS2 live cell chamber
(Bioptechs, Inc., Butler, PA). Transfected cells were grown on the cus-
tomized coverslips that were assembled into the FCS2 chamber, where
temperature was maintained at 37
 
8
 
C, and cells were supplemented with a
 
controlled flow of fresh medium. The chamber was directly mounted onto
the specimen stage of an inverted epifluorescence microscope (Axiovert
405M; Zeiss, Inc.) equipped with a cooled CCD (NU200; Photometrics
Inc.) camera. Images were captured using Oncor Image software.
 
Results
 
The Presence of the PNC Correlates with the 
Transformed Phenotype
 
Since PTB is the only protein component of the PNC thus
far identified, we used a monoclonal antibody, SH54, that
specifically recognizes PTB (see Materials and Methods
and Fig. 4 
 
a
 
) to characterize the PNC in cell nuclei. A large
number of human cancer cell lines and normal human dip-
loid cell lines were examined for the presence of the PNC.
The results showed that the PNC is predominantly present
in cancer cells and is rarely observed in normal primary
cells (Figs. 1 and 2). PNC prevalence, defined as the per-
centage of cells that contains one or more PNCs, showed a
large diversity among the cancer cell lines examined. Some
of the cell lines such as HeLa (endothelial carcinoma, cer-
vix) and T84 (colon carcinoma) showed a PNC prevalence
of 
 
.
 
80%. In contrast, the PNC prevalence of other cell
lines such as SW620 and MG63 ranged from 25 to 50%.
The large variability of PNC prevalence among cancer,
transformed, and primary diploid cells suggests that PNC
prevalence may be correlated with the degree of malig-
nancy. To examine this possibility, we compared PNC
prevalence in two human breast cell lines. We found that
PNC prevalence appeared to be fivefold higher in MDA-
MB-468 cells (American Type Culture Collection, Rock-
ville, MD) isolated from a metastatic mammary adenocar-
cinoma that induces tumors in nude mice, than in Hs 578T
cells (American Type Culture Collection) isolated from a
mammary ductal carcinoma that does not induce tumors
in nude mice (Fig. 2). In addition, when primary human
diploid fibroblasts (WI-38 cells) were transformed by
SV40 large T antigen (WI-38 VA13), the PNC prevalence
rose to 
 
.
 
60% compared to 2% in the nontransformed pa-
rental cells (Fig. 2). It is also noticeable that the size of
PNCs varies from cell to cell (Fig. 1). In some cancer cells,
the structure tended to be larger (Fig. 1, 
 
HeLa
 
 and 
 
WI
 
-
 
38
VA13
 
 cells) and occasionally extended into the nucleolus,
whereas, in other cancer cells, the structure was mostly ob-
served as small dots (Fig. 1, 
 
MG63
 
 cells). However, in the
very small percentage of normal cells that contains the
PNC, the PNC invariably appeared to be a small dot (data
not shown).
 
Characterization of the PNC through the Cell Cycle
 
We have further characterized the PNC in HeLa cell nu-
clei throughout the cell cycle by immunolabeling using
SH54. The PNC is clearly associated with nucleoli in inter-
phase cells. The shape and size of the PNC varies from cell
to cell within the same cell line. As cells progress through
mitosis, the PNC dissociates in prophase cells (Fig. 3 
 
D
 
).
The dissociation appears to be a gradual event. When dou-
ble labeled with the anti-fibrillarin antibody, a more con-
centrated PTB labeling is still visibly associated with the
partially disassembled nucleolus at early prophase (Fig.
3, 
 
D
 
 and 
 
E
 
, 
 
arrows
 
). Both PTB and fibrillarin are diffusely
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localized in metaphase cells (Fig. 3, 
 
G
 
 and 
 
H
 
). At late telo-
phase, the PNC begins to form in the new daughter cell
nuclei before the re-entry of the entire nucleoplasmic pop-
ulation of PTB (Fig. 3 
 
J
 
, 
 
arrows
 
). Double labeling experi-
ments using the anti-fibrillarin antibody showed that the ini-
tial detectable PNCs are spatially associated with nucleolar
regions (Fig. 3, 
 
J
 
 and 
 
K
 
, 
 
arrows
 
). Double labeling experi-
ments using the anti-Sm antibody showed that the re-
establishment of splicing factors in the new daughter cell
nuclei takes place before the formation of the PNC (data not
shown). In addition, the formation of the PNC did not ap-
pear to be affected by the presence of cycloheximide (data
not shown), suggesting that the newly formed PNC is com-
posed of cellular components from the previous cell cycle.
 
Characterization of the PNC in Living Cells
 
To directly visualize the PNC in living cells, a mammalian
expression vector was constructed that expresses a GFP–
PTB fusion protein. Human PTB cDNA (Gil et al., 1991)
was amplified by PCR and inserted into the pEGFP-C1
vector (Clontech Laboratories, Inc.) generating a fusion
protein in which PTB is at the COOH-terminal end of GFP.
The construct was transiently transfected into HeLa cells,
and the expression of GFP–PTB was examined. Proteins
from cells transfected with either GFP–PTB or GFP alone
were analyzed by Western blot using the SH54 antibody
(Fig. 4 
 
A
 
). Cells transfected with the GFP–PTB construct
expressed the fusion protein of expected size (84 kD) and
the endogenous PTB (57 kD; Fig. 4 
 
A
 
, lane 
 
a
 
). Cells trans-
fected by GFP alone showed only the endogenous PTB
protein (Fig. 4 
 
A
 
, lane 
 
b
 
). To examine if the subcellular lo-
calization of the fusion protein is similar to that of the en-
dogenous PTB, the intranuclear localization of the fusion
protein and endogenous PTB was compared (Fig. 4 
 
B
 
). 24 h
after transfection, cells were fixed, immunolabeled with
the SH54 antibody, which recognizes both endogenous
PTB and GFP–PTB, and subsequently probed with Texas
red–conjugated secondary antibody (Fig. 4 
 
B
 
, 
 
a
 
, 
 
red sig-
nal
 
). GFP–PTB alone emitted a green signal (Fig. 4 
 
B
 
, 
 
b
 
).
Comparisons between 
 
a
 
 and 
 
b
 
 reveal that the GFP–PTB
fusion protein and the endogenous PTB were colocalized
to the same nuclear regions, which included both the PNC
(Fig. 4 
 
B
 
, 
 
a
 
 and 
 
b
 
, 
 
arrows
 
) and the nucleoplasm. To ex-
clude the possibility that the formation of the PNC may be
due to the overexpression of the GFP–PTB fusion protein,
we examined cells that do not contain a PNC, as deter-
mined by immunolabeling. We found that the expression
of GFP–PTB at a high level (roughly evaluated by the in-
tensity of the green fluorescence) did not induce the for-
mation of the PNC (Fig. 4 
 
B
 
, 
 
c
 
 and 
 
d
 
, 
 
left cell
 
).
Figure 1. The PNC is predominantly present in human cancer cells.
PNCs were detected by immunolabeling using antibody SH54.
The left column shows the presence of the PNC in human cancer
cells (arrowheads), including HeLa (epithelia carcinoma), MG63
(osteosarcoma), MDA-MB-468 (mammary adenocarcinoma), and
WI-38 VA13 (human lung fibroblast cells WI-38 transformed by
SV40 T). The right column shows that the PNC is generally not
present in normal human diploid cells including Detroit 551 (skin
fibroblast), Wacar (skin fibroblast), HNME (human normal mam-
mary epithelium), and WI-38 (lung fibroblast). Bar, 10 mm.
Figure 2. The percentage of cells that contain the PNC (PNC
prevalence) is correlated with the transformed phenotype. The
histogram indicates the statistical evaluation of PNC prevalence
among human cancer cells and normal diploid cells. 500 cells
from each cell line were examined.
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Using the GFP–PTB fusion protein as a probe, we ob-
served the PNC in living cells. Cells were transiently trans-
fected with the GFP–PTB construct. 12 h after transfec-
tion, cells grown on glass coverslips were moved to a live
cell chamber (see Materials and Methods). The chamber
was mounted onto the stage of a fluorescence microscope,
and images were captured at various time intervals. The
exposure of cells to the excitation light was kept minimal.
Time lapse observations demonstrated that the PNC is a
dynamic structure that makes small movements at the
periphery of and occasionally into the nucleolus over time
(Fig. 5). Closer examination revealed that the PNC ap-
pears to contain substructures whose organization also
changes through time (Fig. 5, 
 
insets
 
). These substructures
appeared to be strand like in some cases (Fig. 5, 
 
inset
 
, 2 h).
In many cells, the PNC changed shape and position within
2–3 h. GFP–PTB did not appear to have an immediate tox-
icity to transfected cells, as cells expressing GFP–PTB pro-
 
gressed through multiple cell cycles and newly divided
cells expressed the fusion protein (data not shown).
 
High Resolution Electron Microscopic Examination of 
the PNC
 
To further analyze the structural characteristics of the
PNC at higher resolution, we examined the PNC in HeLa
cells by electron microscopy. Photooxidation pre-embed-
ding immunolabeling was used to achieve a high degree of
sensitivity and good morphological preservation (Deerinck
et al., 1994). The results of these experiments revealed that
the PNCs are in direct contact with the surface of the nu-
cleolus (Figs. 6 and 7), and occasionally, they extend into
the nucleolus (Fig. 6 
 
C
 
). In addition, the PNCs are irregu-
lar in shape. A clear margin of the structure was not ob-
served at this level as compared to what was revealed at
the light microscopic level. The immunolabeling of PTB in
the PNC appeared to be heterogeneous, with some areas
more intensely stained than others. Higher magnification
micrographs (Fig. 6, 
 
B
 
 and 
 
C
 
) or stereo images from 1-
 
m
 
m–
thick sections viewed at 300 kV (Fig. 7 
 
B
 
) revealed strand-
like structures across the PNC (Figs. 6 and 7 
 
B
 
).
To visualize the basic structural features of the PNC in
optimally fixed cells at high resolution, we examined the
PNC in the same cell by fluorescence and electron micros-
copy. To mark the PNC without immunocytochemical
manipulations, the expression of GFP–PTB was used as a
marker to indicate the localization of the PNC in tran-
siently transfected cells. Transfected cells were photographed,
optimally fixed, and processed for the electron micro-
scopic examination (see Materials and Methods). The flu-
orescence and electron microscopic images of the same
cell are shown in Fig. 8. The nuclear region corresponding
to the PNC appeared to be an electron-dense structure,
which is composed of thick, short strands measuring 
 
z
 
80–
180 nm diam. Each strand appears to be surrounded by
lesser electron-dense areas. The strand-like structure may
correspond to the heterogeneous labeling of the PNC ob-
served in the immunoelectron microscopic examination
using SH54 (Fig. 6). Some of the strands are directly
linked to the surface of the nucleolus (Fig. 8 
 
C
 
, 
 
arrows
 
).
Similar structures were observed in multiple sections. In
some sections, the strands were as long as 1 
 
m
 
m. It is possi-
ble that in three dimensions the strands are connected,
forming a continuous structure.
 
Sequence Requirement for Targeting PTB to the PNC
 
To determine the sequence requirement for targeting
GFP–PTB to the PNC, we generated a series of deletion
mutants of the GFP–PTB fusion protein and analyzed the
subcellular localization of these mutant fusion proteins.
The mutant proteins were designed according to the struc-
tural characteristics of PTB, which has been previously
shown to contain four RNA recognition motifs (RRMs;
Patton et al., 1991; Ghetti et al., 1992). Nine mutants (Fig. 9)
containing various numbers of RRMs from either the NH
 
2
 
or COOH terminus of the protein were made. The inserts
in all mutant constructs were verified by restriction en-
zyme analysis (data not shown). The constructs were tran-
siently transfected into HeLa cells, and the expression of
the mutant proteins was examined by fluorescence micros-
Figure 3. The PNC dissociates at prophase and reforms at late telo-
phase. The horizontal rows show different stages of mitosis. The
left column shows the immunolabeling of the PNC with antibody
SH54, the center column the immunolabeling of fibrillarin with
human anti-fibrillarin antibody, and the right column DNA stain-
ing by Dapi. The dissociation of the PNC at prophase (D) ap-
pears to be a gradual event. A concentrated PTB labeling is still
spatially linked with the partially dissociated nucleolus (D and E,
arrows). Both PTB (G) and fibrillarin (H) are diffusely distrib-
uted in metaphase cells. The earliest detectable PNCs (J, arrows)
in the daughter cell nuclei are associated with nucleolar regions
(K, arrows). Bar, 10 mm.
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copy. All mutant fusion proteins were expressed at a de-
tectable level, as monitored by the expression of GFP. The
subcellular localization of these mutants was examined
(Fig. 10) and compared to the localization of endogenous
PTB (Table I). The result of the analysis demonstrated
that only two mutant fusion proteins, PTB-1 and -4, both
of which contain three RRMs, were localized to the PNC
in transfected cells (Fig. 10 and Table I). Mutants with a
combination of two RRMs, including combinations of RRMs
1 and 2, 3 and 4, or 2 and 3, as well as mutants with only
one RRM were not able to target the fusion protein to the
PNC (Fig. 10 and Table I). These observations suggest
that a minimum of three RRMs are required for GFP–
PTB to be efficiently targeted to the PNC.
To examine if the expression of the mutant GFP–PTBs
interfered with the localization of endogenous PTB in the
PNC, the location of the endogenous PTB was examined
by immunolabeling with SH54 (summarized in Table I).
The result showed that the expression of the wild-type
GFP–PTB and GFP–PTB mutants did not affect the local-
ization of the endogenous PTB in the PNC (Table I). In
addition, the expression of these fusion proteins did not
appear to affect the subcellular distribution of the nucle-
olar protein, fibrillarin, or splicing factors such as SC35
(Table I).
In addition to the requirement of three RRMs for the
localization of GFP–PTB to the PNC, we have also ob-
served some interesting features of these mutant proteins
with respect to their subcellular localization. The GFP–
PTB fusion proteins with an intact NH2 terminus gave rise
to a predominantly nuclear localization. The cytoplasmic
localization of these proteins was hardly detectable (Fig.
10, top row and Table I). In contrast, deletion of the NH2-
terminal RRM resulted in a much more prominent cyto-
plasmic localization of these mutant proteins (Fig. 10 and
Table I). Particularly, the mutant PTB-5, which contained
Figure 4. (A) Both the GFP–
PTB fusion protein and en-
dogenous PTB are ex-
pressed in transfected cells
and are detected at the ex-
pected size by Western blot
using antibody SH54 (lane
a). Only endogenous PTB is
detected in cells transfected
with the GFP construct alone
(lane b). (B) The subcellular
localization of GFP–PTB is
indistinguishable from en-
dogenous PTB. The endoge-
nous PTB (a, red) and the
GFP–PTB fusion protein (b,
green) are colocalized to
both the PNC (arrows) and
the nucleoplasm. The PNC
observed in transfected cells
is not the result of the over-
expression of the protein, as
some cells do not contain a PNC in spite of expressing large amounts of the fusion protein (c and d, left cell). c shows both the immuno-
labeling of endogenous PTB and transiently expressed GFP–PTB; d shows GFP–PTB. Bar, 10 mm.
Figure 5. The PNC is a dynamic structure with small movements over time when observed in living cells. This figure illustrates the ob-
servation of a single cell through time as indicated in all frames. The PNC changes its shape and position over a 3-h period. In the insets,
the PNC appears to contain substructures that are reorganized through time. Bar, 10 mm.
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two RRMs at the COOH terminus, showed a predomi-
nantly cytoplasmic localization (Fig. 10). However, neither
RRM3 nor RRM4 alone is sufficient to direct a strong cy-
toplasmic localization (Fig. 10). These findings suggest
that the NH2 terminus of PTB may be responsible for the
nuclear localization of this protein.
Discussion
We have examined a large number of human cancer and
normal diploid cells and have found that the presence of
the PNC correlates with the transformed phenotype. Our
findings agree with and further extend unpublished data
described in Matera et al. (1995), stating that the PNC is
found predominantly in transformed cells. The correlation
between the PNC and cancer cells suggests that the forma-
tion of the PNC may be the result of oncogenic transfor-
mation. Further support for this suggestion comes from
the controlled observation of a pair of cell lines in which
PNC prevalence increased .25-fold from WI-38 cells, nor-
mal human lung fibroblasts, to their transformed deriva-
tive, WI-38 VA13 cells. In addition, we found that PNC
prevalence varies tremendously among different cancer
cell lines examined, suggesting that PNC prevalence may
correspond to the degree of malignancy. This possibility is
supported by the examination of breast cancer cells, in
which PNC prevalence appears to be 5-fold higher in
MDA-MB-468 cells, derived from a breast metastatic car-
cinoma that induces tumors in nude mice, than in Hs 578T
cells, derived from a breast ductal carcinoma that does not
induce tumors in nude mice. Investigations are currently
underway to examine the correlation between the PNC
and human cancer tissues.
The development of cancer is clearly a multi-step pro-
cess (Knudson, 1971), a chain of events in which the conse-
quence of one change unleashes a cascade of subsequent
alterations. Although the function of the PNC is unknown,
its preferential presence in cancer cells suggests that the
formation of the PNC is part of an evolving process that
transforms normal cells into cancer cells. The formation of
the PNC may result from initial abnormalities and in turn
may promote additional changes during the progression of
cancer. However, it is also possible that the formation of
these nuclear structures merely represents a cellular re-
sponse to overall physiological changes that occur during
cancer formation.
Observations in living and fixed cells at the light and
electron microscopic levels have demonstrated a close as-
sociation between the PNC and the nucleolus. The associ-
ation begins during nucleologenesis at late telophase and
extends to prophase before nucleolar dissociation. Such a
close interaction suggests that the PNC may be linked to
nucleolar activities. It has been documented that nucleoli
undergo significant changes during carcinogenesis (for re-
view see Busch, 1981), including increases in the expres-
sion of certain nucleolar proteins as well as alterations in
Figure 6. The PNC is spatially associated with the nucleolus
when examined at high resolution by electron microscopy. Photo-
oxidation pre-embedding immunocytochemical labeling of the
PNC with SH54 demonstrates that the PNC is in direct contact
with the nucleolus (A–C), and PTB is heterogenously distributed
in the PNC (B and C). The arrowheads indicate the PNC.
Figure 7. Stereo pair images of 1-mm thick sections observed at
300 kV using intermediate voltage electron microscopy reveal in
three dimensions that the PNC is directly linked to the surface of
the nucleoli (A). Images at higher magnification show strand-like
structures. Bars: (A) 4 mm; (B) 1 mm.
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the number and shape of nucleoli. Immunocytochemical
labeling of nucleolar proteins has provided useful markers
in cancer diagnosis and prognosis (Busch, 1981, 1990).
However, the functional significance of the changes in nu-
cleoli during carcinogenesis remains unclear. In normal
cells, the function of the nucleolus has long been shown to
be primarily involved in the biogenesis of preribosomal
particles (for reviews see Busch and Smetana, 1970; Hadji-
olov, 1985; Scheer and Benavente, 1990); more recently,
studies in the yeast system revealed that nucleoli may also
play a role in the processing and transport of poly(A)+
RNA (Schneiter et al., 1995; Tani et al., 1995). During car-
cinogenesis, nucleolar activities may change to accommo-
date the changes in cellular physiology. The spatial associ-
ation between PNCs and the nucleolus as well as the
correlation between PNCs and oncogenic transformation
raise the possibility that the PNC may participate in the
changes in nucleolar activities that occur during carcino-
genesis. However, only when structural components and
the function of the PNC are better understood, can its role
in carcinogenesis be addressed.
The PNC is an electron-dense structure consisting of
multiple strands, some of which are directly linked to the
surface of the nucleolus. These thick strands may corre-
spond with strand-like substructures observed in living
cells (Fig. 5). As compared to the coiled body, which is
densely packed with coiled fibrils (Ramon y Cajal, 1903),
the PNC is loosely packed with thick strands that are sur-
rounded by areas of lesser electron density. The PNC seems
to bear some resemblance to a structure described by Co-
hen et al. (1984; Chung et al., 1984). These investigators
identified protuberances that develop at the nucleolar pe-
riphery in estrogen-stimulated nerve cells (Chung et al.,
1984; Cohen et al., 1984). Examination by electron micros-
copy showed these structures to be electron dense without
well defined margins. Similar to the PNC, they are linked
to the surface of the nucleolus by strands of electron-dense
material (Cohen et al., 1984). Sodium tungstate staining
and DNase digestion on resinless sections suggested that
they contain DNA (Chung et al., 1984; Cohen et al., 1984).
Studies are underway to determine if these protuberances
and the PNC are the same structure.
Using deletion mutagenesis we have analyzed the se-
quence requirement for PTB targeting to the PNC. We
have found that at least three RRMs at either the COOH
or NH2 terminus are necessary and sufficient for the trun-
cated fusion proteins to be localized to the PNC. It is un-
likely that a specific signal involving only a small stretch of
conserved sequences is responsible for the localization of
the protein to the PNC. Analysis of translational regula-
tion by PTB in virus-infected human cells has previously
shown that three RRMs are essential and sufficient for an
efficient binding of PTB to the internal ribosomal entry
sites of viral RNA transcripts (Kaminski et al., 1995). Our
finding that three RRMs are needed for PTB to be local-
ized to the PNC suggests that the localization of PTB in
the PNC may be due to its binding to polypyrimidine tract
containing RNA(s). In addition, we have recently found
that the presence of PTB in the PNC is sensitive to RNase
A treatment (data not shown), further supporting the idea
that the presence of PTB in the PNC is dependent upon its
RNA binding. Our observations agree with and augment
the finding and suggestion by Matera et al. (1995) that sev-
Figure 8. Fluorescence and electron microscopic examination of
the PNC in the same cell. The nuclear region corresponding to
the PNC in the fluorescence micrograph was examined in post-
stained, 80-nm–thick sections. Arrowheads indicate the corre-
sponding nuclear region from fluorescence to electron micro-
scopic images. The PNC is composed of electron-dense, thick,
short strands measuring 80–180 nm diam. These strands are sur-
rounded by less electron-dense areas. Some of the strands are in
direct contact with the surface of the nucleolus. Bars: (A) 10 mm;
(B) 2 mm; (C) 1 mm.
Figure 9. Deletion mutants were generated to analyze the se-
quence requirement for PTB to be localized to the PNC. The mu-
tants are designed according to the four RNA recognition motifs
of the protein.
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eral small RNA polymerase III transcripts containing pyrim-
idine-rich sequences, including multiple Y RNAs, RNase P,
and MRP RNAs, are present in the PNC and that PTB
may therefore bind these RNAs. PTB is an RNA-binding
protein preferentially recognizing pyrimidine-rich se-
quences and has been reported to be involved in multiple
cellular functions including pre-mRNA splicing (Patton et
al., 1993; Gozani et al., 1994; Singh et al., 1995), splice site
selection in alternative pre-mRNA splicing (Lin and Pat-
ton, 1995), RNA polyadenylation (Lou et al., 1996), and
translational regulation of certain viral RNA transcripts
(Hellen et al., 1994; Kaminski et al., 1995; Witherell et al.,
1995). Its capability of shuttling between the nucleus and
cytoplasm suggests that PTB may also be involved in RNA
transport (Pinol-Roma and Dreyfuss, 1992; Michael et al.,
1995). PTB appears to participate in these functions through
the binding to pyrimidine-rich RNA sequences. Thus, it is
possible that PTB serves as a bridge between the pyrimi-
dine tract RNAs and different macromolecules in fulfilling
different cellular functions. However, the association and
function of PTB in the PNC remains to be determined.
In summary, we have extensively characterized the PNC
both in fixed and living cells using PTB as a probe. We
have found that the PNC is a dynamic structure that is in
direct contact with the nucleolus. The association initiates
Figure 10. The subcellular
localization of a series of de-
letion mutants of GFP–PTB
fusion proteins. Deletion of
either RRM 1 or 4 does not
affect the localization of the
fusion protein to the PNC
(GFP–PTB 1 and 4, arrows).
However, deletion mutants
that contain fewer than
three RRMs result in the in-
ability to target the fusion
proteins to the PNC (other
frames). Deletion mutants
that contain RRM1 show a
predominantly nuclear local-
ization (top row), whereas
mutants missing RRM1 show
a much more cytoplasmic lo-
calization (other frames).
The mutant GFP–PTB with
RRMs 3 and 4 shows that the
cytoplasmic localization be-
comes dominant over the nu-
clear localization. Bar, 10 mm.
Table I. Characteristics of the GFP–PTB Deletion Mutant 
Fusion Proteins
PTBs
GFP–PTBs
in the PNC
Endogenous
PTB in the
PNC Fibrillarin SC35 Nucleus Cytoplasm
GFP–PTB 1111 1 1 1 1111 2222
GFP–PTB 1 111 1 1 1 1111 2222
GFP–PTB 2 2222 1 1 1 1111 22
GFP–PTB 3 2222 1 1 1 1111 1
GFP–PTB 4 1111 1 1 1 1111 11
GFP–PTB 5 2222 1 1 1 1 111
GFP–PTB 6 2222 1 1 1 1111 11
GFP–PTB 7 2222 1 1 1 111 11
GFP–PTB 8 2222 1 1 1 1111 111
GFP–PTB 9 2222 1 1 1 1111 111
The number of pluses and minuses indicates a rough quantitation of each activity by
fluorescence intensity. (The single pluses in columns 2–4 indicate that significant
changes were observed.) It is clear that at least three RRMs are required for a proper
targeting of the fusion proteins to the PNC (column 1). The expression of either the
wild-type or the mutant fusion proteins does not affect the pre-existing PNCs (column
2, which shows the localization of the PNC by SH54), the localization of nucleolar
protein fibrillarin (column 3), or the splicing factor, SC35 (column 4). In addition, the
deletion mutants that contain the NH2 terminus of the PTB are localized predomi-
nantly in the nucleus (column 4), whereas the mutants that do not contain the NH2 ter-
minus of the protein show a cytoplasmic localization tendency (column 5).
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at the beginning of the cell cycle and ends at prophase.
The PNC appears to be an electron-dense structure. It is
composed of multiple strands, each measuring 80–180 nm
diam. Some of the strands are in direct contact with the
surface of the nucleolus. Deletion mutagenesis of GFP–
PTB indicates that at least three RRMs, either NH2 or
COOH terminal are required for PTB to be localized to
the PNC, suggesting that the role of PTB in the PNC may
involve its binding to polypyrimidine tract-containing RNAs.
Furthermore, the presence of the PNC is closely associ-
ated with oncogenic transformation. Studies are underway
to further analyze the structural components and func-
tional characteristics of the PNC.
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